Exercise and ischemic preconditioning

Current Cardiology Reviews

Volumn 2, Issue 3, 2006, Pages 153-162

  Crisafulli, Antonio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cardioprotection; Heart; Ischemia; Warm up

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATE; BIMAKALIM; BRADYKININ; CHOLESTEROL; GLIBENCLAMIDE; MANGANESE SUPEROXIDE DISMUTASE; NITRIC OXIDE; OPIATE; OXYGEN; OXYGEN RADICAL; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SULFONYLUREA; SUPEROXIDE DISMUTASE;

ANAEROBIC METABOLISM; BRAIN INFARCTION SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; DIABETES MELLITUS; ENZYME ACTIVATION; EVIDENCE BASED PRACTICE; EXERCISE; EXERCISE INTENSITY; EXERCISE TEST; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC PRECONDITIONING; MYOCARDIAL HIBERNATION; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK FACTOR; RISK REDUCTION; SHEAR STRESS; STUNNED HEART MUSCLE; SURVIVAL; TACHYCARDIA;

EID: 33747272953     PISSN: 15733947     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340306778019469     Document Type: Review

References (157)

1. Murray CJ, Lopez AD. Alternative protections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
2. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. New Engl J Med 2002; 346: 793-801.
3. Morris JN, Heady JA, Raffle P, Roberts CG, Parks JW. Coronary heart disease and physical activity of work. Lancet 1953; 265: 1053-1057, 1111-1120.
4. McElroy CL, Gissen SA, Fishbein MC. Exercise-induced reduction in myocardial infarct size after coronary artery occlusion in the rat. Circulation 1978; 57: 958-962.
5. Froelicher V, Battler A, McKirnam MD. Physical activity and coronary heart disease. Cardiology 1980; 65: 153-190.
6. Morris JN, Everitt MG, Pollard R, Chave SP, Semmence AM. Vigorous exercise in leisure-time: protection against coronary heart disease. Lancet 1980; 2: 1207-1210.
7. Eichner ER. Exercise and heart disease. Am J Med 1983; 75: 1008-1023.
8. Paffenbarger RS, Hyde RT, Wing A, Hsieh C. Physical activity, all-cause mortality, and longevity of college alumni. N Eng J Med 1986; 314: 605-613.
9. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Ann Rev Public Health 1997; 8: 253-287.
10. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA 1988; 260: 945-950.
11. O'Connor GT, Buring JE, Yusaf S, Goldhaber SZ, Olmstead EM. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989, 80: 234-244.
12. Blair SN. Physical activity, fitness, and coronary heart disease. In: Physical activity, fitness and health, Bouchard C, Shephard RJ, and Stephens T (Eds.). Champaign, IL: Human Kinetics, 1994, p.579-590.
13. Sandvick L, Erikssen J, Thoulaw WE, Erikssen G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality among healthy and middle aged Norwegian men. N Engl J Med 1993; 328: 5343-5347.
14. Hull SS Jr, Vanoli E, Adamson PB, Verrier RL, Foreman RD, Schwartz PJ. Exercise training confers anticipatory protection from sudden death during myocardial ischemia. Circulation 1994; 89: 548-552.
15. Myers J. Exercise and cardiovascular health. Circulation 2003; 107, e2-e5.
16. Brown DA, Jew KN, Sparagna GC, Musch TI, Moore RL. Exercise training preserves coronary flow and reduces infarct, size after ischemia-reperfusion in rat heart. J Appl Physiol 2003; 95: 2510-2518.
17. Shephard RJ, Balady GJ. Exercise as cardiovascular therapy. Circulation 1999; 99: 963-972.
18. Leon AS. Exercise following myocardial infarction. Sports Med 2000; 29: 301-311.
19. Hambrecht R, Walther C, Möbius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease. Circulation 2004; 109: 1371-1378.
20. McCartney N. Role of resistance training in heart disease. Med Sci Sports Exerc 1998; 30 (10 suppl.): S396-402.
21. Laughlin MH, McAllister RM. Exercise training-induced coronary vascular adaptation. J Appl Physiol 1992; 73(6): 2209-2225.
22. Laughlin MH. Joseph B. Wolfe Memorial lecture. Physical activity in prevention and treatment of coronary disease: the battle fine is in exercise vascular cell biology. Med Sci Sports Exerc 2004; 36(3):352-62.
23. Gomez-Alamillo C, Juncos LA, Cases A, Haas JA, Romero C. Interactions between vasoconstrictors and vasodilators in regulating hemodynamics of distinct vascular beds. Hypertension 2003; 42 (part2): 831-836.
24. Woodman CR, Muller JM, Laughlin MH, Price EM. Induction of nitric oxide synthase mRNA in coronary resistance arteries isolated from exercise-trained pigs. Am J Physiol 1997; 273: H2575-2579.
25. Gattullo D, Pagliaro P, Marsh N, Losano G. New insight into nitric oxide and coronary circulation. Life Sci 1999; 65: 2167-2174.
26. Green DJ, Maiorana A, O'Driscoll G, Taylor R. Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 2004; 561: 1-25.
27. Hägg U, Wandt B, Bergström G, Volkmann R, Gan LM. Physical exercise capacity is associated with coronary and peripheral vascular function in healthy young adults. Am J Physiol (Heart and Circ Physiol) 2005; 289: H1627-H1634.
28. Domenech R, Macho P, Schwarze H, Sanchez G. Exercise induces early and late myocardial preconditioning in dogs. Cardiovasc Res 2002; 55: 561-566.
29. Lambiase P, Edwards RJ, Cusack MR, Bucknall CA, Redwood SR, Marber MS. Exercise-induced ischemia initiates the second window of protection in humans independent of collateral recruitment. J Am Coll Cardiol 2003; 41: 1174-1182.
30. Michaelides AP, Andrikopoulos GK, Oikonomou EV, et al. Improved myocardial performance during repetitive exercise testing: the role of extracellular superoxide dismutase activity in a model of exercise-induced myocardial preconditioning. Am. Heart J.2003; 146: 160-167.
31. Crisafulli A, Melia F, Tocco F, et al. Exercise-induced and nitro-glycerin-induced myocardial preconditioning improves hemodynamics in patients with angina. Am J Physiol (heart and circ physiol) 2004; 287: H235-H242.
32. Kloner RA, Bolli R, Marban E, Reinlib L, Braunwald E and participants. Medical and cellular implications of stunning, hibernation, and preconditioning. Circulation 1998; 97: 1848-1867.
33. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
34. l adenosine receptors in rabbit heart. Circulation 1991; 84: 350-356.
35. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992; 263: H1107-1112.
36. Vahlhaus C, Schultz R, Post H, Onallah R, Heusch G. No prevention of ischemic preconditioning by the protein kinase C inbibitor staurosporine in swine. Circ Res 1996; 79: 407-414.
37. Gattullo D, Linden RJ, Losano G, Pagliaro P, Westerhof N. Ischaemic preconditioning changes the pattern of coronary reactive hyperaemia in the goat: role of adenosine and nitric oxide. Cardiovasc Res 1999; 42: 57-64.
38. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003; 83: 1113-1151.
39. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 1987; 272: H1470-1476.
40. Asimakis GK, Innerd-McBridge K, Medellin G, Conti VR. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol 1992; 263: H887-894, 1992.
41. Parratt J, Vegh A. Pronounced antiarrhythmic effects of ischemic preconditioning. Cardioscience 1994; 5: 9-18.
42. Cohen MV, Yang XM, Downey JM. Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart. Am J Physiol 1999; 277: H1754-61.
43. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995; 77: 1030-1035.
44. 3 receptors in protection of isolated human atrial muscle against simulated ischemia. Cardiovasc Res 1997; 36:52-59.
45. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrman HC, Lashey WL. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation 1990; 82: 2044-2051.
46. Tomai F, Crea F, Gaspardone A, et al. Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol 1993; 22: 1892-1896.
47. Laskey WK. Benefical impact of preconditioning during PTCA on creatine kinase release. Circulation 1999; 99: 2085-2089.
48. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI-4. Circulation 1995; 91: 37-47.
49. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995; 91: 291-297.
50. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Harder AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996; 334: 7-12.
51. Ishihara M, Sato H, Tateishi H, et al. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis. J Am Coll Cardiol 1997; 30: 970-975.
52. Noda T, Minatoguchi S, Fujii K, et al. Evidence for the delayed effect in human ischemic preconditioning: prospective multicenter study for preconditioning in acute myocardial infarction. J Am Coll Cardiol 1999; 34: 1966-1974.
53. Marber MS, Joy MD, Yellon DM. Is warm-up in angina ischaemic preconditioning? Br Heart J 1994; 72: 213-215.
54. Maybaum SM, Ilan MM, Mogilevsky JM, et al. Improvement in ischemic parameters during repeated exercise testing: a possible model for myocardial preconditioning. Am J Cardiol 78: 1996; 1087-1091.
55. Kay P, Kittelson J, Stewart RAH. Relation between duration and intensity of first exercise and "warm up" in ischemic heart disease. Heart 2000; 83: 17-21.
56. Bilinska M, Rudnicki S, Beresewicz A. Delayed attenuation of myocardial ischemia with repeated exercise in subjects with stable angina: a possible model for the second window of protection? Basic Res Cardiol 2000; 95: 418-423.
57. Kelion AD, Webb TP, Gardner MA The warm-up effect protects against ischemic left ventricular dysfunction in patients with angina. J Am Coll Cardiol 2001; 37: 705-710
58. Tomai F. Warm-up phenomenon and preconditioning in clinical practice. Heart 2002; 87: 99-100.
59. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993; 72: 1293-1299.
60. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 1993; 88: 1264-1272.
61. Bolli R. The late phase of preconditioning. Circ Res 2000; 87: 972-983.
62. Pagliaro P, Gattullo D, Rastaldo R, Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sci 2001; 69: 1-15.
63. ATP channel. Ann Rev Physiol 2000; 62: 79-109.
64. l-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85: 659-665.
65. Leesar MA, Stoddard M, Ahmed M, Broadbent J, Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997; 95: 2500-2507.
66. Leesar MA, Stoddard MF, Xuan YT, Tang XL, Bolli R. Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans. J Am Coll Cardiol 2003; 42: 437-4445.
67. Parrat JR. Protection of the heart by ischemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 1994; 15: 19-25.
68. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77: 611-621.
69. Schultz JEJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibencamide-sensitive mechanism in the rat heart. Circ Res 1996; 78: 1100-1104.
70. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Moll Cell Cardiol 1997; 29: 207-216.
71. Baines CP, Wang L, Cohen MV, Downey JM. Protein tyrosine kinases is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 1998; 30: 383-392.
72. + channels. News Physiol. Sci. 1998; 13: 131-137.
73. ATP-fact or artefact? New thoughts on the mode of action of the potassium channel openers. Cardiovasc Res 1994; 28: 735-737.
74. Gross GJ, Auchampach JA. Role of ATP-drependent potassium channels in myocardial ischemia. Cardiovasc Res 1992; 26: 1011-1016.
75. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70: 223-233.
76. ATP channel. Am J Physiol (Heart Circ Physiol) 1994; 266: 11829-11839.
77. Grover GJ. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia. J Cardiovasc Pharmacol 1994; 24: S18-S27.
78. + channels and myocardial preconditioning. Circ Res 1999; 84: 973-979.
79. Klimt CR, Knatterud GL, Meinert CL, Prout TE. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970; 19: 747-830.
80. Rytter L, Troelsen S, Beck-Nielsen, H. Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985; 8: 230-234.
81. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in digs. Circulation 1994; 89: 1769-1775.
82. Armstrong SC, Kao R, Gao W, et al. Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: effect of a protein phosphate inhibitor, fostriecin. J Moll Cell Cardiol 1997; 29: 3009-3024.
83. + channels. Possible mechanism of cardioprotection. Circ Res 1997; 81: 1072-1082.
84. ATP channel as a receptor for potassium channel openers. J Biol Chem 1996; 271: 8796-8799.
85. ATP channels in preconditioning. Circ Res 2000; 87: 845-855.
86. + channel of heart mitochondria. Am J Physiol (Heart Circ Physiol) 2001; 280: H649-H657
87. + channel protects the ischemic heart. Am J Physiol (Heart Circ Physiol) 2002; 283: H284-H295.
88. ++ overload in rat mitochondria. J Physiol 1999; 519: 347-360.
89. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 2000; 87: 460-466.
90. Vanden Hoek TL, Becker LB, Shao ZH, Li CQ, Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 2000; 86: 541-548.
91. ATP channels. Circ Res 2001; 89: 273-278.
92. Krenz M, Oldenburg O, Wimpee H, et al. Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol 2002; 97: 365-373.
93. Yellon DM, Baxter GF. "A second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Moll Cell Cardiol 1995; 1023-1024.
94. Baxter GF, Marber MS, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 1994; 90: 2993-3000.
95. Baxter GF, Yellon DM. Time course of delayed myocardial protection after transient adenosine A1-receptor activation in the rabbit. J. Cardiovasc Pharmacol 1997; 29: 631-638.
96. l receptor mediates late preconditioning via activation of PKC-δ signaling pathway. Am J Physiol 2002; 283: H296-H301.
97. Ebrahim Z, Yellon DM, Baxter GF. Bradykinin induces delayed cardioprotection in the rat heart via nitric oxide dependent mechanism. Am J Physiol (Heart Circ Physiol) 2001; 281: H1458-1464.
98. Kostitprapa C, Ockaili RA, Kukreja RC. Bradychinin B2 receptor is involved in the late phase of preconditioning in rabbit heart. J Mol Cell Cardiol 2001; 33: 1355-1362.
99. Sun J-Z, Tang X-L, Park S-W, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 1996; 97: 562-576.
100. Zhou XB, Zhai XL, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocites. Circulation 1996; 93: 1177-1184.
101. Kaeffer N, Richard V, Thuillez C. Delayed coronary endothelial protection 24 hours after preconditioning: role of free radicals. Circulation 1997; 96: 2311-2316.
102. ATP, channels. Circ Res 1999; 84: 846-851.
103. Patel HH, Moore J, Hsu AK, Gross GJ. Bw373u86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Moll Cell Cardiol 2001; 33: 1455-1465.
104. Guo Y, Jones WK, Xuan YT, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 1999; 96: 11507-11512.
105. Imagawa J, Yellon DM, Baxter GF. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br J Pharmacol 1999; 126: 701-708.
106. Pagliaro P, Gattullo D, Rastaldo R, Losano G. Involvement of nitric oxide in ischemic preconditioning. Ital Heart J 2001; 2: 660-668.
107. Xi L, Tekin D, Gursoy E, et al. Evidence that NOS2 acts as a trigger and a mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol 2002; 283: H5-H12, 2002.
108. Shinmura K, Tang X-L, Wang Y, et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 2000; 97: 10197-10202.
109. Guo Y, Bao W, Wu W-J, Shimmura K, Tang X-L, Bolli R. Evidence for an essential role of cycooxigenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Res Cardiol 2000; 95: 480-485.
110. Shinmura K, Liu S-Q, Tang X-L et al. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circulation 2000; 102 (suppl. II): II-120, (abstract).
111. Yamashita N, Nishida M, Hoshida S, et al. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 1994; 94: 2193-2199.
112. Hoshida S, Yamashita N, Otsu. K, et al. The importance of manganese superoxide dismutase in delayed preconditioning: involvement of reactive oxygen species and cytokines. Cardiovasc Res 2002; 55: 495-505.
113. Locke M, Tanguay R, Klabunde R, et al. Enhanced post-ischemic myocardial recovery following induction of HSP72. Am J Physiol 1995; 38: H320-H325.
114. Plumier JCL, Ross BM, Currie RW, et al. Transgenic mice expessing the human heat-shock protein 70 have improved postischemic myocardial recovery. J Clin Invest 1995; 95: 1854-1860.
115. l receptor induced delayed preconditioning in rabbits: induction of p38 MAPK activation and Hsp27 phosporylation via tyrosine kinase and protein kinase C-dependent mechanism. Circ Res 2000; 86: 989-997.
116. Powers SK, Locke M, Demirel HA. Exercise, heat shock proteins, and myocardial protection from I-R injury. Med Sci Sports Exerc 2001; 33: 386-392.
117. ATP channels elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res 1999; 85: 1146-1153.
118. Bernardo NL, D'Angelo M, Okubo S, Joy A, Kukreja RC. Delayed ischemic preconditioning is mediated by opening of ATP-sensitive potassium channels in the rabbit heart. Am J Physiol 1999; 276: H1323-1330.
119. Loubani M, Hassouna A, Galinanes M. Delayed preconditioning on the human myocardium: signal transduction and clinical implications. Cardiovasc Res 2004; 61: 600-609.
120. Dawn B, Bolli R. Role of nitric oxide in myocardial preconditioning. Ann N Y Acc Sci 2002; 962:18-41.
121. Xi L, Tekin D, Gursoy E Sallom F, Levasseur JE, Kukreja RC. Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol (Heart Circ Physiol) 2002; 283: H5-HI2.
122. Sasaki N, Sato T, Ohler A, O'Rourke B, Marban E.. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 2000; 101: 439-445.
123. Bolli R, Dawn B, Tang X-L, et al. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 1998; 93: 325-338.
124. Leesar MA, Stoddard M, Dawn B, Jasti VG, Masden R, Bolli R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 2001; 103: 2935-2941.
125. Hill MF, Takano H, Tang XL, Kodani E, Shirk G, Bolli R. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 2001; 104: 694-699.
126. Jneid H, Chandra M, Alshaher M, et al. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests. Circulation 2005; 111: 2565-2571.
127. Kevelaitis E, Peynet J, Mouas C, et al. Opening of potassium channels. The common cardioprotective link between preconditioning and natural hibernation? Circulation 1999; 99: 3079-3085.
128. Koning MMG, Gho BCG, van Klaarwater E, et al. Rapid ventricular pacing produces myocardial protection by non ischemic activation of ATP potassium channels. Circulation 1996; 93: 178-186.
129. Domenech RJ, Macho P, Velez JD, et al. Tachycardia preconditions the infarct size in dogs. Role of adenosine and protein kinase C. Circulation 1998; 97: 786-794.
130. Rinaldi CA, Masani MD, Links AZ, Hall RJ. Effect of repetitive episodes of exercise induced myocardial ischemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischemic preconditioning. Heart 1999; 81: 404-411.
131. Okazaki Y, Kodama K, Sato H, et al. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up. J Am Coll Cardiol 1993; 21: 1597-1604.
132. Paraskevaidis IA, Iliodromitis EK, Mavrogeni S, et al. Repeated exercise stress testing identifies early and late preconditioning. Int J Cardiol 2005; 98: 221-226.
133. Tomai F, Perino M, Ghini AS, et al. Exercise-induced myocardial ischemia triggers the early phase of preconditioning but not the late phase. Am J Cardiol 1999; 83: 586-588.
134. McElroy CL, Gissen SA, Fishbein MC. Exercise-induced reduction in myocardial infarct size after coronary artery occlusion in the rat. Circulation 1978; 57: 958-962.
135. Bowles DK, Farra RP, Starnes JW. Exercise training improves cardiac function following ischemia in the isolated working rat heart. Am J Physiol 1992; 263: H804-H809.
136. Bowles DK, Starnes JW. Exercise training improves metabolic response after ischemia in isolated working rat heart. J Appl Physiol 1994; 76: 1608-1614.
137. Locke M, Tanguay RM, Klabundei RE, et al. Enhanced postischemic myocardial recovery following exercise-induction of HSP 72. Am J Physiol 1995; 269: H320-H325.
138. Hamilton KL, Staib JL, Philips T, Hess A, Lennon SL, Powers SK. Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion. Free Radic Biol Med 2003; 34: 800-809.
139. Yamashita N, Baxter GF, Yellon M. Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mechanism. Heart 2001; 85: 331-336.
140. Davies KJ, Quintanilha AT, Brooks GA, Packer L. Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 1982; 107: 1198-1205.
141. Ji LL. Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med. 1999; 222: 283-292
142. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, Hori M. Exercise provides direct biphasic cardioprotection via manganese super-oxide dismutase activation. J Exp Med 1999; 189: 1699-1706.
143. Welch WJ. Mammalian stress response: cell physiology, structure/function of stress proteins, and implication for medicine and disease. Physiol Rev 1992; 72: 1063-1081.
144. Locke M. The cellular stress response to exercise: role of stress proteins. Exerc Sport Sci Rev 1997; 25: 105-136.
145. Lennon SL, Quindry J, Hamilton KL e al. Loss of exercise-induced cardioprotection after cessation of exercise. J Appl Physiol 2004; 96: 1299-1305.
146. Gho BCG, Schoemaker RG, van den Doel M, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation 1996; 94: 2193-2200.
147. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance. Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit Circulation 1997; 96: 1641-1646.
148. Takaoka A, Nakae I, Mitsunami K, et al. Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning". J Am Coll Cardiol 1999; 33: 556-564.
149. Liem DA, Verdouw PD, Ploeg H, Kazim S, Duncker DJ. Sites of action of adenosine in interorgan preconditioning of the heart. Am J Physiol (Heart Circ Physiol) 2002; 283: H129-H37.
150. Wang YP, Xu H, Mizoguchi K, Oe M, Maeta H. Intestinal ischemia induces late preconditioning against myocardial infarction: a role for inducible nitric oxide synthase. Cardiovasc Res 2001; 49: 391-398.
151. Heusch G, Schultz R. Editorial: remote preconditioning. J Moll Cell Cardiol 2002; 34: 1279-1281.
152. Gross GJ. Remote preconditioning and delayed cardioprotection in skeletal muscle. Am J Physiol (Regul Integr Physiol) 2005; 289: R1562-R1563.
153. Dickson EW, Lorbar M, Porcaro WA, et al. Rabbit heart can be preconditioned via transfer of coronary effluent. Am J Physiol (Heart Circ Physiol) 1999; 277: H2451-H2457.
154. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol (Heart Circ Physiol) 2000; 278: H1571-H1576.
155. Green HJ, Hughson RL, Orr GW, Ranney DA. Anaerobic threshold, blood lactate, and muscle metabolites in progressive exercise. J Appl Physiol 1983; 54: 1032-1038.
156. Ivy JL, Chi MMY, Hintz CS, Sherman WM, Hellendall RP, Lowry OH. Progressive metabolite changes in individual human muscle fibers with increasing work rates. Am J Physiol (Cell Physiol) 1987; 252: C630-C639.
157. Domenech RJ. Preconditioning. A new concept about the benefit of exercise. Circulation 2006, 113: e1-e3.